Medicover AB (MCOV-B) Fair Value & Analysis
Healthcare · SE · Market cap 34.6B SEK
Fair value as of: Jul 16, 2026
From 24 valuation models · updated 5 days ago
Fair value updated Jul 16, 2026, revised from kr 9.94 to kr 124.34 (+1,150.9%) since Jul 5, 2026. Share price +7.3% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 180.33 – kr 282.56 · fair‑value band kr 93.25 – kr 155.42 · the kr 221.00 price screens above the kr 124.34 fair value. As of Jul 16, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Medicover AB (MCOV-B) currently trades at kr 221.00, while our model-based Fair Value estimate is kr 124.34, implying the stock looks roughly 43.7% overvalued today. We read business quality at 51/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Medicover AB generated revenue of 2.4B SEK at a net margin of 3.3%. Revenue grew 8.0% year over year. It earns a return on equity of 13.9%. Net debt stands at 1.4B SEK. Fundamentals as of Jul 16, 2026
Our scenario range runs from kr 93.25 (bear case) to kr 155.42 (bull case); at kr 221.00, the current price sits above that range. The share trades about 24% below its 52-week high and 24% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -19% fair-value upside, at -44%, MCOV-B screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 16, 2026. TTM = trailing twelve months.
About the company
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Medicover AB reported revenue of kr 2.4B in FY2025 versus kr 1.4B in FY2021, a compound +14.6%/yr. Reported net income was kr 77.5M in FY2025, compounding −6.6%/yr from FY2021.
Is MCOV-B fairly valued? → Check now
Recent news
- Does KKR’s (KKR) India Hospital Deal And Fee Shift Reveal A New Earnings Playbook?
- European Growth Stocks With Strong Insider Ownership
- Medicover AB (FRA:5M0B) Q1 2026 Earnings Call Highlights: Strong Organic Growth and Margin ...
- European Growth Stocks With High Insider Ownership In April 2026
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$100.00 | R$25.67 | -74% |
| Fresenius SE FRE | €39.54 | €31.98 | -19% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.76 SGD | 1.28 SGD | -54% |
| Tenet Healthcare Corporation THC | $178.75 | $300.86 | +68% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
| DaVita Inc DVAI34 | R$1,002 | R$1,038 | +4% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,305 | ₹2,546 | -69% |
| Fresenius Medical Care AG FME | €41.25 | €80.11 | +94% |
| Aier Eye Hospital Group 300015 | ¥8.54 | ¥6.73 | -21% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,010 | ₹283.61 | -72% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Medicover AB (MCOV-B) undervalued?
What is the fair value of MCOV-B?
What is the quality score of MCOV-B?
What is the revenue of Medicover AB (MCOV-B)?
What is the net profit margin of MCOV-B?
Does Medicover AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Medicover AB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.